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The objective of this study is to design the biodegradable nanospheres of cationized 
gelatin as a carrier of cellular internalization of plasmid DNA. Ethylenediamine was 
chemically introduced into the carboxyl groups of gelatin to obtain cationized gelatin. 
The gelatin solution was filtered through a glass membrane under a high pressure and 
dropped into 2-butanol, acetone or the mixture to form nanospheres of cationized 
gelatin. The microspheres of cationized gelatin were prepared by the conventional 
water-in-oil emulsion method. The resulting nano- and microspheres of cationized 
gelatin were dehydrothermally treated at 160 °C for different time periods to allow them 
to crosslink chemically. The size of nanospheres prepared by the filtration method was 
changed by the type of solvents used to be 1.86, 0.83 or 0.24 m. The in vitro 
degradation of spheres became faster as the time period of dehydrothermal treatment 
was shorter. The degradation time of spheres in HCl solution linearly increased with an 
increase in the crosslinking time, irrespective of the sphere size. However, in the 
collagenase solution, when compared at the similar crosslinking density, the smaller 
spheres were degraded more slowly than the larger ones. The plasmid DNA 
incorporated in the nanospheres was released from the nanospheres with their 
degradation. The nanospheres incorporating plasmid DNA were internalized into cells, 
and intracellularly degraded with time to release plasmid DNA. The time period of 
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plasmid DNA release prolonged by increasing that of nanospheres degradation.  
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 Intracellular delivery of plasmid DNA has been tried for gene transfection 
either by viral or non-viral carriers system. Viral carriers of adenoviruses, retroviruses, 
adeno-associated viruses, and lentivirus possess the inherently high efficiency of gene 
transfection and have been extensively used for biological researches [1-7]. However, 
there are some problems to be resolved for the clinical trials, such as the immunological 
and/or toxic responses toward the carriers themselves. The genetic modulations of viral 
carriers have been attempted to reduce their biological responses [8]. As other different 
approaches, non-viral carriers have been explored to demonstrate several advantages 
over the viral carriers. For the non-viral transfection system, naked plasmid DNA alone 
or the complexes with cationic liposomes, cationic lipids, and cationic polymers have 
been utilized [9-12]. However, the level of gene transfection is low compared with that 
of viral carriers, and the time period is shorter. To maintain the gene expression for a 
long time period, repeated transfection has been performed, but the frequent use of 
non-viral carriers is practically not acceptable and sometimes may cause toxicity. As 
one technology to resolve the issues, drug delivery system (DDS) of plasmid DNA is 
effective. Various sustained release of plasmid DNA with polymeric implants and 
hydrogels have been being investigated [13-19]. 
 Gelatin has been extensively used for industrial, pharmaceutical, and medical 
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applications and the bio-safety has been proven through its long clinical use as 
biomaterial and drug ingredients [20]. Other advantages of gelatin include the 
availability of samples with various physicochemical natures and the simple chemical 
modification. Hydrogels of gelatin were effective in the sustained release of proteins 
and low-molecular-weight drug [21-27]. Cationized gelatin can readily be prepared by 
introducing amine residues to the carboxyl groups of gelatin. The biodegradable 
microspheres of cationized gelatin functioned as a good carrier for plasmid DNA 
release [28, 29]. The plasmid DNA was released from the gelatin microspheres as a 
result of their degradation [21].  
 In this study, the biodegradable nanospheres with a narrow size distribution 
were prepared from cationized gelatin to allow plasmid DNA to internalize into cells for 
the intracellular sustained release. A filtration method was used to prepare nanosopheres 
and the degradability of nanospheres was charged by altering their crosslinking 
condition in preparation. The nanospheres degradation was examine in the HCl solution 
or collagenase solution. We examined the cellular internalization of cationized gelatin 
nanospheres with different crosslinking densities and the subsequent sustained release 





Materials and Methods 
 
Preparation of cationized gelatin  
 The carboxyl groups of gelatin, with an isoelectric point of 9.0 and the 
weight-avaraged molecular weight of 99,000, prepared by an acidic process of pig skin 
(Nitta Gelatin Inc., Osaka, Japan), were converted by chemically introducing amino 
groups for cationization of gelatin [21]. Ethylenediamine (Wako Pure Chemical 
Industries, Ltd., Osaka, Japan) was added at a molar ratio of 50 to the carboxyl groups 
of gelatin into 250 ml of 100 mM phosphate-buffered solution (pH 5.0) containing 5.0 g 
of gelatin. Immediately after that, the solution pH was adjusted to 5.0 by adding 11 M 
HCl aqueous solution. Further, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride salt (Nacalai Tesque. Inc., Kyoto, Japan) was added at a molar ratio of 3 
to the carboxyl groups of gelatin. The reaction mixture was agitated at 37 °C for 18 hr 
and then dialyzed against double-distilled water (DDW) for 48 hr at room temperature. 
The dialyzed solution was freeze-dried to obtain a cationized gelatin. When determined 
by the conventional 2,4,6-trinitrobenzene sulfonic acid (TNBS, Wako Pure Chemical 
Industries, Ltd., Osaka, Japan) method [30], the percentage of amino groups introduced 




Preparation of cationized gelatin microspheres and nanospheres 
 Spheres with different sizes were prepared from cationized gelatin by two 
methods. For the first method, aqueous solution of 10 wt% cationized gelatin (10 ml) 
was preheated at 40°C and then added dropwise into 600 ml of olive oil preheated at 
40°C, while an impeller stirring at 400 rpm was used for 10 min to yield a water-in-oil 
emulsion. The emulsion temperature was decreased to 4 °C for the natural gelation of 
gelatin solution. The resulting microspheres were washed three times with cold acetone, 
collected by centrifugation (5,000 rpm, 4°C, 5 min), fractionated in size by sieves with 
an aperture of 32 m and air-dried at room temperature. The non–cross linked and dried 
gelatin microspheres (100 mg) were placed in a vacuum oven (Sato vacuum machinery 
industrial Co., LTD., Tokyo, Japan) at 160°C for different time periods to allow them to 
dehydrothermally crosslink.  
 The second preparation was done according to the filtration method reported 
previously [31]. Briefly, aqueous solution of 2.5 wt% cationized gelatin (10 ml) was 
preheated at 40 °C and applied to an apparatus of emulsion preparation (External 
pressure type micro kit, SPG Technology Co. Ltd., Miyazaki, Japan). The solution was 
filtered under a pressure of 350 kPa through a grass membrane with homogenous pores 
of 0.2 or 0.6 m (SPG membrane, SPG Technology Co. Ltd., Miyazaki, Japan) and 
8 
 
dispersed in 2-butanol, acetone, and the mixture to prepare a water-in-oil emulsion. The 
resulting emulsion was air-dried at room temperature to obtain non-crosslinked 
cationized gelatin nanospheres. The non–crosslinked and dried gelatin microspheres 
(100 mg) were placed in vacuum oven at 160 °C for different time periods to allow 
them to dehydrothermally crosslink. The shape of crosslinked gelatin microspheres was 
observed by a transmission electron microscope or a light microscope. 
 
Measurement of water content and crosslinking density of cationized gelatin 
microspheres and nanospheres 
 Cationized gelatin microspheres or nanospheres dehydrothermally crosslinked 
(2 mg) were fully swollen in DDW for 3 hr at 37 °C to reach an equilibrium state. Then, 
the picture of swollen spheres and dried ones before swelling were taken under 
microscope (Olympus Corp., Tokyo, Japan). The diameter of 400 cationized gelatin 
microspheres and nanospheres in the swollen and dried states was measured to calculate 
the respective volumes, Vs and Vd. The water content was calculated by following 
equation; Water content = Vs-Vd/Vs×100 (%). The crosslinking density of cationized 
gelatin microspheres or nanospheres was calculated by the following equation 
(Flory-Huggins equation); ln (1-Φ2)+ Φ2+χΦ22+ν1(νe/V0)(Φ21/3-Φ2/2)=0, where Φ2 is the 
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volume fraction of polymer at equilibrium (i.e., in the fully swollen sample), χ is the 
Flory-Huggins interaction parameter, ν1 is the molar volume of water, νe is the effective 
number of chains in the network, and V0 is the volume of unswollen (i.e., dry) polymer 
network. The νe/V0 is defined as the effective network chain concentration or effective 
chain density (in the unit of mol/cm3). From the volume of spheres, the crosslinking 
density per sphere was calculated. 
 
Evaluation of in vitro degradation of cationized gelatin microspheres and 
nanospheres 
  Cationized gelatin microspheres or nanospheres dehydrothermally crosslinked 
(10 mg) were fully swollen in 750 l of DDW for 12 hr at 25 °C. Then, 750l of 2 N 
HCl aqueous solution was added and incubated at 25 °C for various time periods. The 
solution was centrifuged at 5000 rpm, 25°C for 5 min while 200 l of supernatant was 
collected. After that, 200 l of fresh 1 N HCl aqueous solution was added and 
continued to incubate at 25 °C. To measure the amount of cationized gelatin degraded 
by HCl, the adsorption of supernatant collected at 260 nm was measured by an 
ultraviolet-visible (UV) spectroscopy (DU® 800 Spectrophotometer, Beckman Coulter, 
Inc., Fullerton, CA).  Similar degradation was performed in 600 ng/ml of aqueous 
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solution of collagenase 1A (Sigma-aldrich, Inc., St. Louis, MO). These samples were 
used for each experiment independently unless mentioned otherwise. 
 
In vitro release of plasmid DNA from cationized gelatin microspheres and 
nanospheres and in vitro degradation of spheres 
 The plasmid DNA of firefly luciferase (GL3) was radioiodinated according to a 
chloramine T method [32]. Briefly, 200 l of 200 g/ml plasmid DNA solution was 
added into 100 l of 0.5 M potassium phosphate-buffered (KPB) solution (pH7.5) 
containing 0.5 M NaCl. Then, 5 l of Na125I (740 MBq/ml in 0.1 M NaOH aqueous 
solution, NEN Research Products) solution and 100 l of 0.05 M KPB solution (pH7.2) 
containing 0.02 mg of chloramine T and 0.5 M NaCl were added to the plasmid DNA 
solution. After agitation at room temperature for 2 min, 100 l of DDW containing 0.4 
mg of sodium pyrosulfite (SMS, Nacalai Tesque Inc., Kyoto, Japan) was added to stop 
the radioiodination. The resulting mixture was passed through a PD-10 column (GE 
healthcare UK Ltd., Buckinghamshire, UK) to remove uncoupled, free 125I molecules to 
obtain an aqueous solution of 125I-labeled plasmid DNA. The absorbance ratio at 
wavelengths of 260 nm was measured to determine the concentration of 125I-labeled 
plasmid DNA. The radioiodinated plasmid DNA solution (100 l) was dropped onto 10 
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mg of cationized gelatin microspheres and nanospheres dehydrothermally crosslinked, 
followed by leaving at 4 °C for 12 hr to prepare the microspheres incorporating 
125I-labeled plasmid DNA. Then, the microspheres was washed with 10 mM 
phosphate-buffered saline solution (PBS) by centrifugation, and incubated in 1.5 ml of 
1M HCl at 25 °Cfor different time periods. The radioactivity of microspheres 
remaining was measured to evaluate the time profile of plasmid DNA release from 
microspheres. The in vitro degradation of gelatin nanospheres incorporating 125I-labeled 
plasmid DNA was evaluated similarly. Following the incubation of nanospheres in the 
HCl solution, the amount of gelatin solubilized in PBS was determined by the UV 
spectroscopic absorption in the same procedure as described above at different time 
intervals. 
 
Preparation of mesenchymal stem cells 
 Mesenchymal stem cells (MSC) were prepared from the bone marrow of 
3-week-old, male Wister rats (Shimizu Laboratory Supplies Co., Ltd., Kyoto, Japan) 
according to the conventional procedure reported [33]. Briefly, both the ends of rat 
femurs were cut away from the epiphysis, and the bone marrow was flushed out using a 
syringe (21 gauge needle) with 1 ml of PBS. The cell suspension was centrifuged and 
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resuspended in 4 ml of alpha minimum essential medium (MEM) supplemented with 
15 vol% fetal calf serum (FCS), penicillin (50 U/ml), and streptomycin (50 U/ml) 
(standard medium) and placed into two 25 cm2 flasks (Iwaki Glass Co., Funabashi, 
Chiba, Japan), followed by culturing at 37 °C in a 95% air-5% carbon dioxide 
atmosphere. The medium was exchanged 3 days after the culture and thereafter every 3 
days. When the cells became sub-confluent, 7 to 10 days culture later, they were 
detached by treatment with PBS containing 0.25 wt% trypsin and 0.02 wt% 
ethylenediaminetetraacetic acid for 5 min at 37 °C, and subcultured at a density of 
2×104 cells/cm2. When proliferated in a sub-confluence condition, the cells were used 
for the following experiments. 
 
Evaluation of cellular internalization of cationized gelatin microspheres and 
nanospheres 
 Cationized gelatin microspheres and nanospheres were labeled by fluorescein 
isothiocyanate (FITC) according to the procedure reported [32], while the Cy5 labeling 
of plasmid DNA was performed by using Label IT® Cy5 Labeling Kit (Mirus®, 
Madison, WI) according to the manufacturers’ instructions. The Cy5-labeled plasmid 
DNA was incorporated into each sphere by the same procedure mentioned above. The 
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transfection experiments for MSC were performed by the conventional and reverse 
transfection methods [34]. For the conventional transfection method, MSC were seeded 
on each well of 6 well multi-dish culture plate (Corning Inc., Corning, NY) at a density 
of 5 × 104cells/well and cultured in 1 ml of MEM medium with 15 vol% FCS for 24 
hr. Then, the medium was exchanged to FCS-free -MEM medium, and the 
microspheres and nanospheres incorporating plasmid DNA were added to each well. 
The transfection culture was performed for 6 hr, and thereafter the cells were incubated 
in -MEM with FCS further for 1, 3, and 7 days. For the reverse transfection method, 
the anionized derivatives of gelatin was prepared and the anionized gelatin solution (1 
mg/ml) and different amounts of Pronectin® (Sanyo Chemical Industries Ltd., Kyoto, 
Japan) were placed into each well of a 6 well culture plate and left at 37 °C for 1 hr for 
their coating. After PBS washing, microspheres or nanospheres incorporating plasmid 
DNA were added into each well, and the well was washed with PBS 30 min later. Next, 
MSC (5 × 104 cells/well) were seeded into the well treated, followed by cell culture in 
the -MEM medium with 15 vol% FCS for 1, 3, and 7 days. At different time intervals 
after the transfection culture for appropriate intervals with the microspheres or 
nanospheres incorporating plasmid DNA, cells were washed and fixed with 0.25 wt% 
glutaraldehyde solution in PBS. Imaging data of cells were collected on an Olympus 
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Fluoview FV300 confocal laser scanning microscope (Olympus Corp., Tokyo, Japan) 
and processed with Adobe Photoshop 6.0 software (Adobe Systems Inc., San Jose, CA). 
On the other hand, after the transfection culture with the microspheres or nanospheres 
incorporating plasmid DNA, the cells were treated in cold acetate-buffered solution 
containing 0.3 vol% acetic acid, 0.085 M NaCl, and 5.0 mM KCl for 1 min, then the 
cells were washed with cold PBS to remove the microspheres or nanospheres bound 
onto the surface of cells. The cells were collected by the trypsinization and ten thousand 
cells were measured by the fluorescence activated cell sorter (FACSCalibur, Becton, 
Dickinson, and Company, Franklin Lakes, NJ) with Cell Quest Pro Software. The 
percentage of FITC or Cy5 -positive cells was calculated by setting the background 
population as 98% negative when analyzing control cells [35]. Experiments were 
performed independently 3 times for each group. 
 
Statistical analysis 
Data were expressed as means ± standard deviations. Data were analyzed using 




Preparation of cationized gelatin microspheres and nanospheres 
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 Table 1 shows the preparation conditions and characterization of cationized 
gelatin microspheres and nanospheres. Cationized gelatin spheres with various sizes 
were prepared by changing the emulsification method and solvent used. Cationized 
gelatin nanospheres prepared by the filtration method had nano-order ranges of size 
with a narrow size distribution. The nanospheres size was changed by changing the 
solvent type even for the same glass membrane. The microspheres with a larger 
distribution in size were prepared by the stirring method. The sphere size did not change 
by the procedure of plasmid DNA incorporation (data not shown). 
 Figure 1 shows the microscopic pictures of cationized gelatin microspheres 
and nanospheres. Every cationized gelatin microsphere had a spherical shape with 
smooth surface.  
 Figure 2 shows the water content of cationized gelatin microspheres and 
nanospheres prepared. The size of microspheres with 0.24 m in diameter was too small 
to measure their size in the swollen state. As the time period of dehydrothermal 
treatment became longer, the water content of spheres became lower. No dependence of 
spheres size on their water content was observed. 
    
Degradation profiles of cationized gelatin microspheres and nanospheres 
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 Figure 3 shows the degradation profiles of microspheres and nanospheres with 
different times of dehydrothermal treatment. The degradation of microspheres and 
nanospheres became slower with an increase in the treatment time. 
 Figure 4 shows the degradation profiles of microspheres and nanospheres with 
different sizes. The time profile of nanospheres degradation was similar for every size. 
On the other hand, the microspheres were degraded more slowly. 
 Figure 5 shows the relationship between the HCl degradation of microspheres 
and nanospheres and their crosslinking density. Irrespective of the spheres type, their 
degradation time was linearly correlated with their crosslinking density.  
 Figure 6 shows the relationship between the spheres degradtion in collagenase 
solution and their crosslinking density. In the collagenase degradation, the linear 
dependence was not observed. When compared at the same crosslinking density, the 
smaller nanospheres were degraded slowly compared with larger spheres. Crosslinking 
density, defined as the crosslinking number per gelatin molecule, of the smaller spheres 
was higher than that of large spheres. 
 Figure 7 shows the relationship between the collagenase degradation of 
microspheres and nanospheres and their crosslinking number per gelatin molecule. A 




Release profiles of plasmid DNA from cationized gelatin microspheres and 
nanospheres 
 Figure 8 shows the time profiles of cationized gelatin nanospheres degradation 
and plasmid DNA release. Although the initial burst of plasmid DNA release was large 
compared with that of nanospheres degradation, their decrement pattern was similar. 
The nanospheres were degraded completely on day 24 when the plasmid DNA was 
finished to be released. The similar time profiles were observed for every type of 
spheres (data not shown). 
 
Cellular internalization of cationized gelatin nanospheres and thier intracelluar 
behavior 
 Figure 9 shows the cellular internalization of FITC-labeled cationized gelatin 
nanospheres. The percentage of nanospheres internalized into cells by the reverse 
transfection method was significantly higher than that of conventional method. 
 Figure 10 shows the cellular internalization of FITC-labeled cationized gelatin 
microspheres and nanospheres. Nanospheres with sizes of 0.22 and 0.83 m were 
internalized into cells whereas those with the sizes of 1.86 and 7.8 m were not. The 
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percentage of smaller nanospheres internalized was significantly higher than that of 
larger ones. 
 Figure 11 shows the time profiles of the intracellular remaining of nanospheres 
incorporating plasmid DNA and the plasmid DNA incorporated. The nanospheres used 
were crosslinked by dehydrothermal treatment for 48 and 120 hr. The nanospheres 
treated for 120 hr were retained in the cells for a long time period compared with those 
for 48 hr. The plasmid DNA remained in the cells for a long time period for 
nanospheres prepared by 120 hr dehydrothermal treatment.  
 
Discussion 
 The present study demonstrates that the nanospheres of cationized gelatin were 
a good carrier to allow plasmid DNA to internalize into cells and subsequently release 
intracellularly. The cellular internalization of nanospheres was greatly influenced by 
their size and the subsequent intracellular release of plasmid DNA was governed by the 
degradability of nanospheres. The nano-orders spheres could be prepared effectively by 
the filtration method and their distribution in size was narrow compared with those 
prepared by the conventional stirring method (Table 1). The plasmid DNA was released 
from the nanospheres as a result of their degradation as reported previously [21]. The 
prolonged time period of plasmid DNA release in the cells was observed for the 
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nanospheres with slower degradability which can be change by the time period of 
dehydrothermal treatment (Figure 11).  
The filtration method was effective in preparing nanospheres with a narrow 
size distribution. It is possible that the narrow size distribution of nanospheres resulted 
from the permeation of gelatin solution through the membrane with a homogenous pore 
size. This procedure will generate effectively the same volume of gelatin solution. 
When the gelatin solution was poured into the non-solvent of gelatin, gelatin molecules 
were precipitated to form spheres. Since the concentration and volume of gelatin 
solution poured are similar, the size of gelatin precipitates would become similar. The 
size depended on the type of solvents used (Table 1). In acetone, the size of 
nanospheres was very small. This is because acetone has a strong dehydration property 
compared with 2-butanol. It is likely that the solution of cationized gelatin was strongly 
dehydrated in acetone, resulting in formation of small-size nanospheres due to the 
strong precipitation. The degradation profiles of nanospheres depended on the time 
period of dehydrothermal treatment in preparation. The dehydrothermal treatment 
enables gelatin molecule to intramolecularly crosslink between the carboxyl and 
hydroxyl or amino groups by excluding water from molecules. Longer treatment 
increased the crosslinking extent of gelatin molecules. It is apparent that the increase in 
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the time period of dehydrothermal crosslinking resulted in the higher crosslinking 
density of microspheres and nanospheres prepared (Figures 4 and 5). It is highly 
conceivable that higher crosslinking density of spheres brought about their slower 
degradation [36]. A good correlation of spheres degradation and their crosslinking 
density was observed in the HCl test (Figure 5). However, the correlation was not in the 
degradation test of collagenase solution (Figure 6). This can be explained in terms of 
the crosslinking homogeneity and the molecular size of HCl and collagenase molecules. 
Irrespective of the spheres size, as the crosslinking was homogenous in the spheres, it is 
likely that the degradation rate of spheres depends on their crosslinking density. The 
higher the crosslinking density, the longer the time period of spheres degradation. 
However, the molecular size of collagenase is much larger than that of HCl. 
Consequently, the degradation by collagenase will be greatly influenced by the 
crosslinking density of microspheres and nanospheres. When the crosslinking density 
per one sphere is same, the molecular density per one microsphere will be lower for 
larger spheres than that of larger ones. As a result, the small spheres would be degraded 
slowly (Figure 6). 
 Small nanospheres were internalized into cells, in remarked contrast to larger 
ones. Since MSC are non-phagocytic cells, it is known that the cells cannot take up 
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larger particles [37, 38]. In this study, the size dependence of spheres internalization 
was observed (Figure 10). The nanospheres prepared for longer treatment time in 
dehydrothermal crosslinking were slowly degraded even inside the cells compared with 
those for the shorter treatment time (Figure 11). The longer retention of plasmid DNA 
in the cells was detected for the nanospheres slowly degraded (Figure 11). This 
strongly suggests that the nanospheres were degraded intracellularly with time, resulting 
in the release of plasmid DNA incorporated. It is concluded that the filtration method 
was effective in preparing biodegradable gelatin nanospheres with a narrow size 
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Figure 1. Microscopic pictures of cationized gelatin microspheres and nanospheres with 
sizes of (A) 0.24, (B) 0.83and (C) 7.80 m. 
 
Figure 2. Water content of cationized gelatin microspheres and nanospheres as a 
function of dehydrothermal crosslinking time period. The size of microspheres used is 
(○) 0.85, (△) 1.86 or (□) 7.8 m. 
 
Figure 3. In vitro degradation profiles of cationized gelatin nanospheres with the size of 
0.85 m dehydrothermally crosslinked at 160 °C for (○) 48, (●) 72, (△) 96, and (▲) 
120 hr. 
 
Figure 4. In vitro degradation profiles of gelatin microspheres and nanospheres 
dehydrothermally crosslinked at 160 °C for 120 hr. The size of microspheres used is (○) 
0.24, (●) 0.85, (△) 1.86 or (▲) 7.8 m. 
 
Figure 5. Relationship between the time period of microspheres and nanospheres 
degradation and their crosslinking density per sphere. The microspheres were degraded 
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in 1 N HCl solution at 25 °C. The size of microspheres used is (●) 0.85, (△) 1.86 or (▲) 
7.8 m. 
 
Figure 6. Relationship between the time period of microspheres and nanospheres 
degradation and the crosslinking density per sphere. The microspheres and nanospheres 
were degraded in 600 ng/ml collagenase solution at 37 °C. The size of microspheres 
used is (●) 0.85, (△) 1.86 or (▲) 7.8 m. 
 
Figure 7. Relationship between the time period of microspheres and nanospheres 
degradation and the crosslinking number per gelatin molecule. The microspheres and 
nanospheres were degraded in 600 ng/ml collagenase solution at 37 °C. The size of 
microspheres used is (●) 0.85, (△) 1.86 or (▲) 7.8 m. 
 
Figure 8. The time profiles of radioactivity remaining of 125I-labeled plasmid DNA (○) 
and the degradation of cationized gelatin nanospheres (●). The microspheres with the 
size of 0.83 m dehydrothermally treated at 160 °C for 72 hr were degraded in 1 N HCl 




Figure 9. Cellular internalization of FITC-labeled nanospheres with the size of 0.24 m 
24 hr after culture with MSC by the conventional and reverse transfection methods. *, p 
< 0.05; significant between the two groups. 
 
Figure 10. Confocal laser microscopy images of cellular internalization of cationized 
gelatin nanospheres incorporating plasmid DNA 24 hr after culture with MSC. Green: 
FITC-labeled cationized gelatin nanospheres. Red: Cy5-labeled plasmid DNA. The size 
of nanospheres used is (A) 0.24 and (B) 0.83 m. (C) Percent internalized of 
FITC-labeled nanospheres with sizes of 0.24 and 0.83 m. *, p < 0.05; significant 
between the two groups. 
 
Figure 11. 
Time profiles of cellular internalization of different FITC-labeled nanospheres 
incorporating Cy5-labeled plasmid DNA. The size of nanospheres used is 0.24 m and 
their crosslinking time is (□) 48 or (■) 120 hr. (A) Time profiles of percent cellular 
internalization of nanospheres. (B) Time profiles of percent cellular internalization of 
plasmid DNA incorporated in nanospheres. *, p < 0.05; significant between the two 
groups. 
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Table 1.   Preparation and characterization of gelatin microspheres and nanospheres.
mu s ca on me o  pore s ze p ere s ze mo ven
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acetonefiltration (0.2 m) c)
a) The pore size of glass filters used for microspheres and nanospheres preparation
b) Mean ± standard error 
c) Cannot be measured  
Table 1. Doi et al.
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Figure 11. Doi et al.
